2m 2m 2m 2m 2m 2m 2m
GRIFOLS SP ADR-B (GRFS)
NASDAQ
$7.20+$0.02 (+0.21%)
Price as of Jun 23, 2026 4:10 PM EDT- $5.0BMarket Cap
- -14.51%1-Year Change
- Drug Manufacturers - GeneralIndustry
GRIFOLS SP ADR-B (GRFS)
$7.20+$0.02 (+0.21%)
GRFS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.18 | ||
Change | -$0.10 (-1.37%) | ||
Open | $7.38 | ||
High | $7.40 | ||
Low | $7.16 | ||
Previous Close | $7.28 | ||
Volume | 656,348 | ||
30-Day Average Volume | 629,184 | ||
1-Week Change | -5.40% | ||
1-Month Change | -10.03% | ||
1-Year Change | -14.51% | ||
3-Year Change | -18.24% | ||
5-Year Change | -57.89% | ||
Fundamentals | |||
Shares Outstanding | 680.6M | ||
Total Assets | $19.7B | ||
Market Cap | $5.0B | ||
Enterprise Value | $4.1B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 07/02/2026 | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 01/04/2016 | ||
Earnings & Revenue
Annual Dividend Yield